Liver tumor ablation with a needle-based device
Part of Cancer, Digestive system clinical trials.
This trial tests a needle-based device that uses heat or cold to destroy liver tumors. It is for people with primary or secondary liver cancer who cannot have surgery or a transplant.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with liver cancer (either starting in the liver or spreading from elsewhere).
- You are not a candidate for surgery or a liver transplant.
- Your liver function is reasonably good (not severely damaged).
- You are at least 18 years old and have a life expectancy of 3 months or more.
- You are willing and able to attend all study visits and procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a focused ultrasound therapy called histotripsy to destroy liver tumors that are close to major blood vessels and cannot be surgically removed. The goal is to see if this non-invasive approach is safe and effective for tumors that are otherwise hard to treat.
This trial tests a heat-based treatment for liver cancer tumors that uses multiple methods to destroy cancer cells. It may help people with liver tumors that haven't spread and who are healthy enough for treatment.
This study tests an investigational drug called IP-001 given after surgery or microwave ablation for liver cancer. The goal is to help prevent the cancer from coming back.
This trial studies different ways to place treatments inside the liver to control liver tumors when they can’t be removed with surgery or ablation. It may help certain people by improving how well the tumor is treated while keeping liver function safer.
This trial tests a new combination treatment that uses heat (ablation) and other therapies to destroy liver tumors. It's for people who cannot have surgery or choose not to, and whose tumor is a specific size.
This trial tests whether adding the drug IP-001 to tumor ablation (microwave or irreversible electroporation) helps control colorectal cancer that has spread to the liver. The goal is to find the best dose and see how the immune system responds.
Hear when a new Liver Tumors trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.